Celator Pharmaceuticals - Articles and news items

Jazz Pharmaceuticals to acquire Celator for $1.5 billion

Industry news / 31 May 2016 / Victoria White, Digital Content Producer

The transaction advances Jazz Pharmaceuticals’ growth strategy and adds Celator’s investigational therapy Vyxeous to the company’s portfolio…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+